Held from the 5th to the 8th of May 2024 in Atlanta, USA, the ISPOR 2024, the conference brought together professionals in health economics and outcomes research (HEOR). Researchers, healthcare leaders, and decision-makers came together to exchange knowledge on healthcare accessibility and effectiveness. The 2024 conference explored themes related to AI, machine learning, and patient-centered research. It highlighted the importance of integrating technology and patient perspectives to improve decision-making on healthcare quality and market access.
Evidence Prime presented the following:
Poster:
Health State Utilities for Allergic Rhinitis - An AI-Supported Systematic Review.
Allergic rhinitis (AR) impacts populations globally and requires health state utility values (HSUVs) to determine the cost-effectiveness of treatments. This study utilized artificial intelligence to conduct a systematic review, identifying nine studies and providing HSUVs for 58 health states. The research identified data gaps in specific geographic regions and age groups.
Evidence Prime’s participation at ISPOR Atlanta highlighted the role of AI in evidence synthesis. Artur Nowak represented the organization in discussions regarding the integration of technology in healthcare. The findings from the HSUV study support future economic evaluations and resource allocation. We continue to develop methodologies for AI-supported systematic reviews.


